Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAX: Microcrystalline Paclitaxel Coated Balloon for Femoropopliteal Artery Disease
NCT02145065Completed
- Sponsor
- Balton
- Start
- Sep 2014
- Primary completion
- Sep 2017
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Balton. Primary endpoint: Angiographic Late Lumen Loss at 6 months. Started Sep 2014; status: completed.
Beyond the preview
Go deeper on NCT02145065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02145065.